|
Procter & Gamble Health Ltd |
Pharmaceuticals - Multinational |
|
|
BSE Code |
|
500126 |
|
|
|
ISIN Demat |
|
INE199A01012 |
|
|
|
Book Value |
|
485.4698795 |
|
|
|
Mar.Cap(Rs.Cr) |
|
7,842.50 |
|
|
|
P/E |
|
34.60 |
|
|
|
Face Value |
|
10 |
|
|
|
|
|
|
|
|
|
|
|
|
Years | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Dec 2018 | Debt-Equity Ratio | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | Long Term Debt-Equity Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | Current Ratio | 2.70 | 2.92 | 3.68 | 5.98 | 5.40 | Fixed Assets | 4.78 | 4.78 | 4.75 | 4.57 | 4.44 | Inventory | 9.83 | 9.54 | 7.99 | 7.31 | 6.26 | Debtors | 12.35 | 15.56 | 13.01 | 11.20 | 8.99 | Interest Cover Ratio | 409.05 | 604.26 | 292.60 | 0.00 | 0.00 | PBIDTM (%) | 27.90 | 25.20 | 26.18 | 28.34 | 107.90 | PBITM (%) | 25.62 | 22.77 | 23.21 | 26.17 | 105.41 | PBDTM (%) | 27.84 | 25.17 | 26.10 | 28.34 | 107.90 | CPM (%) | 20.95 | 19.71 | 20.50 | 20.91 | 101.28 | APATM (%) | 18.66 | 17.28 | 17.53 | 18.74 | 98.79 | ROCE (%) | 43.16 | 35.97 | 27.53 | 18.81 | 76.73 | RONW (%) | 33.56 | 29.17 | 21.96 | 13.85 | 73.79 |
|
|
|
|